<DOC>
	<DOCNO>NCT02976051</DOCNO>
	<brief_summary>Aim : To improve curability radiotherapy HNSCC patient identify hypoxic FAZA-PET scanning</brief_summary>
	<brief_title>DAHANCA 33 : Image Guided Dose-escalated Radiotherapy Patients With Hypoxic HNSCC</brief_title>
	<detailed_description>Prospective phase II study aim improve outcome hypoxic resistent patient identify FAZA-PET . Inclusion : Patients must fulfill follow : Positive hypoxic FAZA-PET Scanning ( describe DAHANCA 24 - see citation ) Stage III-IV , Squamous cell carcinoma larynx , pharynx oral cavity ( HPVneg ( oropharynx ) Indication hyperfractionated accelerated radiotherapy concommitant cis-platin nimorazole</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Stage IIIIV larynx , pharynx , oral cavity Hypoxic FAZAPET positive Indication primary radiochemotherapy Informed consent HPV positive oropharynx cancer Primary surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>